Manchester Financial’s Bristol-Myers Squibb BMY Stock Holding History

Manchester Financial’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-507	Closed	-$32K	–	152
2021 Q1	$32K	Buy	507 +200	+65%	+$12.4K	0.01%	241
2020 Q4	$19K	Hold	307	–	–	0.01%	288
2020 Q3	$19K	Hold	307	–	–	0.01%	240
2020 Q2	$18K	Hold	307	–	–	0.01%	244
2020 Q1	$17K	Sell	307 -175	-36%	-$10.7K	0.01%	230
2019 Q4	$31K	Buy	+482	New	+$27.6K	0.01%	195
2019 Q3	–	Sell	-402	Closed	-$18K	–	99
2019 Q2	$18K	Buy	+402	New	+$18.7K	0.01%	254

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Manchester Financial's BMY Position: Q2 2021 in Review

Manchester Financial sold out of Bristol-Myers Squibb (BMY) in Q2 2021, closing a stake of 507 shares — an estimated $32K sold.

Manchester Financial first reported a position in BMY in Q2 2019 and held it in 7 quarters. The position peaked at $32K in Q1 2021. 2,369 funds tracked by Wall St. Rank hold BMY as of Q2 2021.

Manchester Financial reported no remaining Bristol-Myers Squibb position as of Q2 2021 after selling out during the quarter.
Manchester Financial sold 507 Bristol-Myers Squibb shares in Q2 2021, an estimated $32K.
Manchester Financial first reported a position in Bristol-Myers Squibb in Q2 2019 and held it in 7 quarters.
Manchester Financial's Bristol-Myers Squibb position peaked at $32K in Q1 2021.
2,369 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2021.

Based on Manchester Financial's 13F filing for Q2 2021, filed 21 Jul 2021.